2004, Number S3
II. Universal leucodepletion: Cost/Benefit Analysis
Contreras M
Language: Spanish
References: 0
Page: 41
PDF size: 21.71 Kb.
Text Extraction
Further to a Consensus Conference in Edinburgh, the UK published guidelines with indications for leucodepletion (LD) in 1998. These were:• For intrauterine transfusions and for neonates and infants up to one year of age.
• Severe aplastic anaemia, to reduce allograft failure.
• When CMV-safe components are indicated.
• To manage/prevent febrile non-haemolytic transfusion reactions (FNHTR) for long-term red cell transfusion-dependent patients (e.g. thalassaemics) or where the use of buffy code depleted components does not work.